within Pharmacolibrary.Drugs.V_Various.V08C_MagneticResonanceImagingContrastMedia.V08CA08_GadobenicAcid;

model GadobenicAcid
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.8666666666666664e-06,
    adminDuration = 600,
    adminMass = 100 / 1000000,
    adminCount = 1,
    Vd = 0.00017,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.00013000000000000002,
    k12 = 4.083333333333333e-06,
    k21 = 4.083333333333333e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>GadobenicAcid</td></tr><tr><td>ATC code:</td><td>V08CA08</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>100</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.17</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.6</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Gadobenic acid, also known as gadobenate dimeglumine, is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance visualization of blood vessels and tissues. It is approved for use in adults and children and is commonly used today for diagnostic imaging.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following a single intravenous dose.</p><h4>References</h4><ol><li><p>Swan, SK, et al., &amp; LaFrance, ND (1999). Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. <i>Investigative radiology</i> 34(7) 443–448. DOI:<a href=\"https://doi.org/10.1097/00004424-199907000-00001\">10.1097/00004424-199907000-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10399633/\">https://pubmed.ncbi.nlm.nih.gov/10399633</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V08CA08 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end GadobenicAcid;
